Postoperative Chemotherapy for Medulloblastoma

J Gordon Millichap

doi:10.15844/pedneurbriefs-19-3-8

Postoperative Chemotherapy for Medulloblastoma

Pediatric Neurology Briefs

Volume 19 (2005): Issue 3

By: J Gordon Millichap

Open Access

|Mar 2005

Abstract

The survival rate and cognitive function of 43 children, age <3 years, with medulloblastoma treated with intensive postoperative chemotherapy alone, without radiotherapy, were determined at the University of Wurzburg and other centers in Germany Chemotherapy consisted of three two-month cycles of cyclophosphamide, methotrexate, vincristine, carboplatin, and etoposide.

References

Rutkowski S Bode U Deinlein F Ottensmeier H Warmuth-Metz M Soerensen N Treatment of early childhood medulloblastoma by postoperative chemotherapy alone N Engl J Med 2005 Mar 352 10 978 986 10.1056/NEJMoa042176 15758008
Open DOI Search in Google Scholar Back to article
DeAngelis LM Chemotherapy for brain tumors--a new beginning N Engl J Med 2005 Mar 352 10 1036 1038 10.1056/NEJMe058010 15758016
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-19-3-8 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 22 - 23

Published on: Mar 1, 2005

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Postoperative Chemotherapy,

Medulloblastoma,

Asymptomatic Leukoencephalopathy

© 2005 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 19 (2005): Issue 3